The Effect of Mobile Health Application on Posttraumatic Growth in Women Diagnosed With Breast Cancer
Launched by GAZI UNIVERSITY · Feb 19, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a mobile health application can help women diagnosed with breast cancer grow emotionally after their treatment, a process known as posttraumatic growth. The goal is to provide support and information that can help these women cope with the challenges they face after treatment, like fear of recurrence and emotional distress. The study will involve 56 women who have finished their cancer treatment and are beginning their recovery. To participate, women must be over 18 years old, have been diagnosed with breast cancer, and have completed their treatment.
Participants will use the mobile app for eight weeks after their treatment, receiving helpful information and resources designed to support their emotional well-being. At the end of the trial, researchers will collect data to see how effective the app was in promoting emotional growth. It's important to note that women with certain psychiatric conditions or those who have had previous cancers may not be eligible for this study. Overall, this trial aims to improve the quality of support available to women recovering from breast cancer by using innovative digital tools.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Being over 18 years of age
- • Diagnosed with breast cancer Stage I-II-III-IV
- • Having undergone breast cancer surgery
- • To have completed cancer treatment,
- • Being at the beginning of the remission period,
- • Being able to read and write
- • Having a cell phone with Android software
- Exclusion Criteria:
- • Having a diagnosed psychiatric illness,
- • Receiving hormone therapy only,
- • Having had any cancer before,
- • Having a communication barrier (not speaking Turkish, speech/hearing impairment, etc.)
- • Being visually impaired
- • Criteria for Exclusion from the Sample During the Study
- • Not logging into the information and counseling panel of the mobile health application
- • Wanting to leave study
- • Failure to complete final tests
- • Death of the participant
About Gazi University
Gazi University, a leading research institution based in Ankara, Turkey, is committed to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university integrates cutting-edge research with clinical practice to explore new therapeutic approaches and enhance existing treatments. Gazi University adheres to the highest ethical standards and regulatory guidelines, ensuring the integrity and safety of its clinical trials. By fostering partnerships with healthcare professionals and academic institutions, Gazi University aims to contribute significantly to the global scientific community and address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported